Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1025 of 1467 entries
View as:

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

Phase: N/A Priority: Normal
NCT ID: NCT05669989 Org: User:
Start: 04/05/23 End: 11/30/26 Due: 11/30/27

A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients

Phase: N/A Priority: Normal
NCT ID: NCT03463135 Org: User:
Start: 05/07/18 End: 03/10/20 Due: 03/10/21

Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00709904 Org: User:
Start: 06/30/08 End: 01/31/10 Due: 01/31/11

Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00386191 Org: User:
Start: 09/30/06 End: 12/31/08 Due: 12/31/09

Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)

Phase: N/A Priority: Normal
NCT ID: NCT00653341 Org: User:
Start: 01/31/00 End: 10/31/01 Due: 10/31/02

Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China

Phase: N/A Priority: Normal
NCT ID: NCT05624112 Org: User:
Start: 11/25/22 End: 01/25/24 Due: 01/25/25

A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03776227 Org: User:
Start: 01/25/19 End: 04/22/19 Due: 04/22/20

Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT00258947 Org: User:
Start: 09/30/05 End: 01/31/07 Due: 01/31/08

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

Phase: N/A Priority: Normal
NCT ID: NCT00135941 Org: User:
Start: 08/31/05 End: 09/30/07 Due: 09/30/08

Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT02289963 Org: User:
Start: 01/31/15 End: 04/30/16 Due: 04/30/17

Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis

Phase: N/A Priority: Normal
NCT ID: NCT03583658 Org: User:
Start: 06/30/18 End: 09/02/18 Due: 09/02/19

SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01086254 Org: User:
Start: 05/31/10 End: 12/31/11 Due: 12/31/12

Dermacyd Femina (Lactic Acid) Pocket BR - Compatibility

Phase: N/A Priority: Normal
NCT ID: NCT00783861 Org: User:
Start: 10/31/08 End: - Due: -

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00230178 Org: User:
Start: 04/30/04 End: 12/31/07 Due: 12/31/08

HP184 in Chronic Spinal Cord Injury Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00093275 Org: User:
Start: 10/31/04 End: 12/31/05 Due: 12/31/06

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02749890 Org: User:
Start: 05/09/16 End: 05/31/18 Due: 05/31/19

Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)

Phase: N/A Priority: Normal
NCT ID: NCT00077818 Org: User:
Start: 06/30/02 End: - Due: -

Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01328522 Org: User:
Start: 05/31/11 End: 09/30/11 Due: 09/30/12

A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01148615 Org: User:
Start: 07/31/10 End: 12/31/11 Due: 12/31/12

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)

Phase: N/A Priority: Normal
NCT ID: NCT02585778 Org: User:
Start: 10/23/15 End: 04/03/17 Due: 04/03/18

Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00791544 Org: User:
Start: 11/30/08 End: 11/30/09 Due: 11/30/10

Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.

Phase: N/A Priority: Normal
NCT ID: NCT00783939 Org: User:
Start: 09/30/08 End: - Due: -

Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride

Phase: N/A Priority: Normal
NCT ID: NCT00924573 Org: User:
Start: 05/31/09 End: 03/31/10 Due: 03/31/11

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

Phase: N/A Priority: Normal
NCT ID: NCT01121835 Org: User:
Start: 02/28/10 End: 03/31/12 Due: 03/31/13

A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT05849922 Org: User:
Start: 06/06/23 End: 01/09/25 Due: 01/09/26